CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

(University of Pennsylvania School of Medicine) Genetically edited immune cells can persist, thrive, and function months after a cancer patient receives them.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news